<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04916691</url>
  </required_header>
  <id_info>
    <org_study_id>19-007896</org_study_id>
    <nct_id>NCT04916691</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Erector Spinae Plane Blocks</brief_title>
  <official_title>Erector Spinae Plane Block for Rib Fractures: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the feasibility of using the ultrasound-guided&#xD;
      erector spinae plane blocks to provide additional pain relief to patients with rib fractures&#xD;
      in the Emergency Department (ED) and Intensive Care Unit (ICU).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural success rate</measure>
    <time_frame>12 months</time_frame>
    <description>Measuring the Number of successful ESPB procedures performed in the ED and ICU</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Rib Fractures</condition>
  <arm_group>
    <arm_group_label>EPSB for rib fractures</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>EPSB for rib fractures</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EPSB for rib fractures</intervention_name>
    <description>EPSB for rib fractures</description>
    <arm_group_label>EPSB for rib fractures</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Standard of care weight-based optimal Ropivacaine dosing for ESPB</description>
    <arm_group_label>EPSB for rib fractures</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years old or older.&#xD;
&#xD;
          -  Patients with one or more acute traumatic rib fractures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to position appropriately.&#xD;
&#xD;
          -  Unconscious or heavily sedated.&#xD;
&#xD;
          -  Patients who are critically ill such that care should not be delayed for regional&#xD;
             anesthesia.&#xD;
&#xD;
          -  Patients under the age of 18 years old.&#xD;
&#xD;
          -  Vulnerable populations including prison inmates and pregnant patients.&#xD;
&#xD;
          -  Overlying skin infection, wound, or dressing/equipment (i.e., Chest tube).&#xD;
&#xD;
          -  Inability to visualize target anatomy or by ultrasound or anatomy prohibitive for&#xD;
             other reasons to perform procedure successfully.&#xD;
&#xD;
          -  Known or documented allergy to ropivacaine or other amide local anesthetic.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Stephens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>June 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Daniel Stephens</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rib Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

